Experience with Real-Time Continuous Glucose Monitoring in Newborns with Congenital Hyperinsulinemic Hypoglycemia

Ayşe Anık1, Münevver Kaynak Türkmen1, Abdullah Barış Akcan1

  • 1Pediatrics, Division of Neonatology, Adnan Menderes University School of Medicine, Aydin, Turkey.

Insights

Real-time continuous glucose monitoring (RT-CGMS) accurately assesses glucose levels in newborns with congenital hyperinsulinemic hypoglycemia (CHH) during normal blood sugar. This technology can reduce the need for frequent capillary blood tests in these vulnerable infants.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Medical Devices

Background:

  • Congenital hyperinsulinemic hypoglycemia (CHH) requires vigilant monitoring in children to prevent neurological damage.
  • Current capillary blood glucose monitoring methods are insufficient for detecting all hypoglycemia episodes.

Purpose of the Study:

  • To evaluate the accuracy and effectiveness of a real-time continuous glucose monitoring system (RT-CGMS) in neonates diagnosed with CHH.

Main Methods:

  • RT-CGMS sensors were used in newborn patients for a minimum of 6 days.
  • Bland-Altman analysis was employed to compare RT-CGMS data with capillary blood glucose measurements.

Main Results:

  • A high correlation was observed between RT-CGMS and capillary glucose readings, particularly during normoglycemia.
  • While the false positive rate for hypoglycemia was notable, RT-CGMS demonstrated potential for earlier detection of hypoglycemic events.

Conclusions:

  • RT-CGMS provides accurate glucose monitoring in normoglycemic neonates with CHH.
  • The use of RT-CGMS can significantly decrease the number of required capillary blood samples in pediatric CHH patients.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
674
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
26.9K